Last reviewed · How we verify
NCT03655938
Piezocision-assisted Orthodontic Treatment Combined With Alveolar Bone Regeneration
Phase 4 trial testing Piezocision combined minimally invasive alveolar bone regeneration in Patients Requiring Mandible Orthodontic Treatment in 10 participants. Completed in 20 March 2018.
20 March 2018
Quick facts
| Lead sponsor | University of Liege |
|---|---|
| Phase | Phase 4 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 10 |
| Start date | 20 March 2017 |
| Primary completion | 20 March 2018 |
| Estimated completion | 20 March 2018 |
| Sites | 1 location across Belgium |
Drugs / interventions tested
- Piezocision combined minimally invasive alveolar bone regeneration
Conditions studied
- Patients Requiring Mandible Orthodontic Treatment — all drugs for Patients Requiring Mandible Orthodontic Treatment →
Sponsor
University of Liege
Who can join
18 and older, any sex, with Patients Requiring Mandible Orthodontic Treatment. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study was designed to enroll a series of 10 consecutive patients who met the inclusion criteria. Patients were treated in the Department of Orthodontics and Dento-Facial Orthodopedics of the University of Liège. Two senior's orthodontists and two senior's periodontists were involved in the orthodontic treatment and in the surgical procedures respectively. All clinical, radiographic and periodontal measurements and all orthodontic parameters were performed at baseline and after the orthodontic treatments. Tree examiners collected the overall data.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Buccal bone regeneration combined with piezocision in adult orthodontic patients: Clinical, 3D radiographic, and patient-reported outcomes.
Charavet C, Lecloux G, Vandenberghe B, Lambert F. · · 2021 · cited 4× · PMID 33289660 · DOI 10.1016/j.jormas.2020.10.005
Verify or expand the search:
- PubMed search for NCT03655938
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other University of Liege trials
Trials by the same sponsor.
- NCT07523178 — Effects of a Targeted Prevention Program on Change-of-Direction Biomechanics and Performance in Elite Female Soccer Play · NA · not yet recruiting
- NCT07472400 — Mobility, Strength, and Functional Outcomes Before Surgery, at 3 Months, and at 6 Months After Hip Arthroscopy for Femor · not yet recruiting
- NCT07331779 — Effect of tDCS Timing on Motor Recovery in Acute Stroke Rehabilitation · NA · not yet recruiting
- NCT07237893 — Impact of a Physical Activity Intervention on Cardiometabolic Health, Mental Health, and Lifestyle Factors. · NA · not yet recruiting
- NCT06964282 — Iliopsoas (IPB) and Pericapsular Nerve Group (PENG) Blocks Comparison on Analgesia and Recovery After Total Hip Arthropl · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03655938 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Liege
- Last refreshed: 31 August 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03655938.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing